mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.9 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
0.0062 |
0.9 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.9 |
mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
0.038 |
0.9 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.9 |
mRNA |
AMG-706 |
FIMM |
pan-cancer |
AAC |
0.037 |
0.9 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.9 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |